Skip to main content
Fig. 2 | Infectious Diseases of Poverty

Fig. 2

From: Access to quality diagnosis and rational treatment for tuberculosis: real-world evidence from China–Gates Tuberculosis Control Project Phase III

Fig. 2

DST coverage rate (a) and distribution of different drug susceptibility tests method (b) for bacteriologically confirmed TB patients in 2015 and 2018, disaggregated by province. Source: TB Information Management System and Global Tuberculosis Report 2016 and 2019. DST drug susceptibility test, TB tuberculosis, RMT rapid molecular tests

Back to article page